Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.

Permanent link
https://hdl.handle.net/10037/10654
DOI
https://doi.org/10.1093/rheumatology/kew040
Thumbnail
View/Open
(PDF)
Date
2016-04-22
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Barratt-Due, Andreas; Fløisand, Yngvar; Lang, Hilde Elisabeth; Kvam, Ann Kristin; Holme, Pål Andre; Bergseth, Grete; Tjønnfjord, Geir Erland; Mollnes, Tom Eirik
Abstract
Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment.
Description
Full text source is available at: https://doi.org/10.1093/rheumatology/kew040
Publisher
Oxford University Press
Series
Volume 55, Issue 7
Citation
Barratt-Due A, Fløisand Y, Lang HEL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE. Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome. Rheumatology. 2016
Metadata
Show full item record
Collections